Inflation has rebounded with a vengeance from its pandemic-induced recession lows. The US headline inflation rate surged to levels not seen since Ronald Reagan’s presidency, while the Eurozone’s Harmonised Index of Consumer Price (HICP) rose to the highest level in its entire 30-year lifespan.
Astraveus SAS bags €16.5m in seed financing
Latest NewsFrench cell and gene therapy manufacturing specialist Astraveus SAS had raises €16.5m in seed money to advance its automated, microfluidic Cell and Gene Therapy manufacturing platform.
New BIOTECH insight newsletter out
Latest NewsBreaking news from biotechnology and the German stock market are in the focus of the new issue of BIOTECH Insight, the newsletter of Deutsche Börse AG.
Fresh money for Carbios
Latest NewsCarbios SAS has announced a capital increase of around €122m that may grow up to €141m.
Closed Loop Medicine appoints new COO
AppointmentsThe appointment of Kate Woolland as new Chief Operating Officer of London-based Closed Loop Medicine Ltd supports delivery of the Company’s product and partnership programs.
First island with zero waste
BackgroundTilos marks the first island to achieve 100% diversion from landfill with an 87% recycling rate.
Biotech companies challenged in times of inflation
OpinionInflation has rebounded with a vengeance from its pandemic-induced recession lows. The US headline inflation rate surged to levels not seen since Ronald Reagan’s presidency, while the Eurozone’s Harmonised Index of Consumer Price (HICP) rose to the highest level in its entire 30-year lifespan.
Smarter, faster, cheaper: Veeva shows how
Latest NewsThis year’s Veeva R&D and Quality Summit in Madrid, accentuated the current trends and needs of the pharma and life sciences industries.
Santhera licences vamorolone rights to Catalyst Pharmaceuticals
Latest NewsSanthera Pharmaceuticals Holding has exclusively granted the rights to commercialise its Duchenne muscular dystrophy drug vamorolone in North America to Catalyst Pharmaceuticals Inc.
BioSenic halts ALLOB development
Latest NewsBioSenic SA has suspended its Phase II proof-of-concept trial on fracture healing with its allogeneic cell therapy ALLOB.
Neogap fully takes over TCER Oncology shares
Latest NewsSwedish personalised immunotherapy specialist Neogap Therapeutics AB has acquired the remaining shares of its subsidiary, TCER Oncology AB through two new shareholders.